Navigation Links
AngioGenex Presents Data on its Id Targeted Anti-Angiogenesis Inhibitors at Two Scientific Conferences
Date:2/3/2009

n Avastin, the current leader in this therapeutic area. A new approach is needed because of increasing data-supported concerns about the high cost of Avastin relative to the limited increase in the lifespan of patients gained with its use."

Company Profile: AngioGenex, Inc. is actively engaged in the discovery, acquisition and development of anti-cancer molecules that act by inhibiting either the Id genes or proteins to prevent the formation of new blood vessels into tumors (angiogenesis). The Company's technology is based on the research of Dr. Robert Benezra and his colleagues at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York City who established that activation of the Id genes is required for the formation of new blood vessels into tumors, allowing tumors to grow and metastasize. Dr. Benezra demonstrated that the absence of the Id genes in animals results in a highly significant inhibition of tumor growth and a reduction in the size of mature tumors. The research of Dr. Benezra on the role of the Id genes in tumor formation has been widely recognized for its important therapeutic implications.

This press release may contain forward-looking statements that involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements, including risks or uncertainties related to the ability of AngioGenex to raise subsequent, substantial additional financing, to complete clinical development of AngioGenex products, and the ability of the Company to successfully develop and market AngioGenex products and technologies. These statements represent the judgment of management as of this date and are subject to risks and uncertainties that could materially affect the Company. AngioGenex undertakes no obligation to publicly release the results of any revisions to such forward-looking statements that may be made to reflect rece
'/>"/>

SOURCE AngioGenex Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. William Garland Joins AngioGenexs New Board of Directors
2. AngioGenex Appoints New CEO to Direct Development of Anti-Cancer Drugs
3. AngioGenex Reviews 2008 Achievements and Sets Goals for 2009
4. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
5. Touching 418 Billion Lives, Hepatitis Still Presents Significant Threat to Global Health
6. Touching 418 Million Lives, Hepatitis Still Presents Significant Threat to Global Health
7. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
8. Sangamo BioSciences Presents Data Demonstrating In Vivo Protection Against HIV Infection by CCR5-ZFN Therapeutic
9. Arpida Presents Preclinical and Clinical Data on Iclaprim at ICAAC
10. Arpida Presents Preclinical Data on AR-2474 at ICAAC
11. Resverlogix Presents Key Apo-Al/HDL Scientific Data at DALM
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Vermillion, Inc. (Pink Sheets: VRML), ... C. Wallen, Ph.D. Chief Scientific Officer, Senior ... Laboratories, will be joining its board of ... ,, "Bill brings more than 20 ... and biotechnology," said Gail Page, Vermillion Executive ...
(Date:12/14/2009)... -- Boston Scientific Corporation (NYSE: BSX ) ... $2 billion aggregate principal amount of its senior notes ... offering consists of $850 million of 4.50 percent notes ... due January 2020 and $300 million of 7.375 percent ... use the net proceeds for general corporate purposes, including ...
(Date:12/14/2009)... US-based thermoforming company, has completed the delivery of Brookfield Engineering’s ... to a plastic enclosure with a smaller footprint and more ... ... (PRWEB) December 14, 2009 -- ThermoFab, a US-based thermoforming company, ... – helping Brookfield move from sheet metal to a plastic ...
(Date:12/11/2009)... Therapeutics, Inc., a biopharmaceutical company focused on improving ... cardiovascular and muscle disease, today announced the publication ... crucial role in the progression of amyotrophic lateral ... neuromuscular synaptic regeneration in mice. The findings, ... journal Science , reveal miR-206 as a ...
Breaking Biology Technology:Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 2Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 3Thermofab Helps Brookfield Engineering Move To A Compact Custom Plastic Enclosure 2miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease 2
... Call to Be Held Tomorrow, Wednesday, September 26th at ... (Nasdaq: KERX ) announced today that it will ... one of its Phase II portfolio,products for a territory ... tomorrow, Wednesday, September 26, 2007, at,8:30am EDT. Michael S. ...
... Glycominds Ltd., a biodiagnostics,company specializing in glycan biomarkers ... cancer, announced today that has,entered the Biomolecular Photonic ... the Government of Israel to improve in-vivo imaging ... BMP consortium was,approved for three years and was ...
... Innovations, Inc. (SBi),a single-source provider of products, technology and ... its PRECISE SD(TM) Volar Distal,Radius Locking Plate system to ... plate geometry is based on computer analysis of CT ... the Hamann Todd,Osteological Collection at the Cleveland Museum of ...
Other Biology Technology:Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance 2Glycominds Joins Biomolecular Photonic (BMP) Consortium to Develop New Molecular Imaging Technique 2Small Bone Innovations Introduces New Distal Radius Plating System to Repair Complex Fractures 2Small Bone Innovations Introduces New Distal Radius Plating System to Repair Complex Fractures 3Small Bone Innovations Introduces New Distal Radius Plating System to Repair Complex Fractures 4
(Date:12/11/2009)... how bacteria under stress collectively weigh and initiate different ... how humans make strategic decisions that affect their health, ... Their study, published this week in the early online ... Academy of Sciences , was accomplished when the scientists ... the complex interplay of genes and proteins that colonies ...
(Date:12/11/2009)... . , Montreal, December 11, 2009 ... prevents cancer. In the December 11 edition of the ... Universit de Montral and the Universit de Sherbrooke explain ... cancer-causing activity of cytokines, hormones that are culprits in ... and people exposed to asbestos. , "Excessive cytokine ...
(Date:12/11/2009)... profits have traditionally been limited by the ... seasons can be short. Thanks to researchers ... being introduced that offer growers the ability ... economic bonuses for both producers and consumers. ... blackberry called "primocane-fruiting", which bear fruit on ...
Breaking Biology News(10 mins):Bacteria provide new insights into human decision making 2Bacteria provide new insights into human decision making 3Bacteria provide new insights into human decision making 4Bacteria provide new insights into human decision making 5Scientists identify natural anti-cancer defenses 2New management methods extend blackberry season 2Sangamo BioSciences Reports Third Quarter 2009 Financial Results 60710 1Sangamo BioSciences Reports Third Quarter 2009 Financial Results 60710 2Sangamo BioSciences Reports Third Quarter 2009 Financial Results 60710 3Sangamo BioSciences Reports Third Quarter 2009 Financial Results 60710 4Sangamo BioSciences Reports Third Quarter 2009 Financial Results 60710 5Sangamo BioSciences Reports Third Quarter 2009 Financial Results 60710 6Sangamo BioSciences Reports Third Quarter 2009 Financial Results 60710 7Sangamo BioSciences Reports Third Quarter 2009 Financial Results 60710 8Regence Foundation Announces Largest Set of Quarterly Grant Awards in Its History 60707 1Regence Foundation Announces Largest Set of Quarterly Grant Awards in Its History 60707 2Regence Foundation Announces Largest Set of Quarterly Grant Awards in Its History 60707 3DIATHERIX Laboratories Presents at Homeland Security Conference 14726 1DIATHERIX Laboratories Presents at Homeland Security Conference 14726 2
... be analysed in a 30 million follow up to last ... study of the genetics behind common diseases. The seven-fold increase ... researchers to look at a 25 diseases as well as ... to statins. , Funded by the Wellcome Trust, this new ...
... the path and estimates the time evolution took to get ... that this tree, an icon of evolution, may need to ... 13 advance online issue of Nature, researchers at Rockefeller University ... that insects have adopted a strategy to detect odors that ...
... in a heart healthy diet reduced low-density cholesterol (bad ... health claims, according to researchers., "We looked at macadamia ... health claim for tree nuts, while other tree nuts ... diet," says Dr. Amy E. Griel, a recent Penn ...
Other Biology News:Largest ever study of genetics of common disease just got bigger 2Insects evolved radically different strategy to smell 2Insects evolved radically different strategy to smell 3Macadamia nuts can be included in heart healthy diet 2
RABBIT ANTI HUMAN TRRAP (CT) Immunogen: Recombinant C-terminal kinase-related domain of human TRRAP....
...
SHEEP ANTI DEHYDROEPIANDROSTERONE...
... Edited by N.C. Price ... detailed information on protein chemistry ... characterization of proteins. Data on ... Chromatography, crystalization, size determination, amino ...
Biology Products: